(Q42281537)

19 October 2017

Objective measurement of therapeutic response in breast cancer using tumour markers (English)

1 reference

19 October 2017

Robertson JF

1

1 reference

19 October 2017

Pearson D

2

1 reference

19 October 2017

Price MR

3

1 reference

19 October 2017

Selby C

4

1 reference

19 October 2017

Blamey RW

5

1 reference

19 October 2017

Howell A

6

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 October 1991

1 reference

British Journal of Cancer

19 October 2017

1 reference

19 October 2017

64

1 reference

19 October 2017

4

1 reference

19 October 2017

757-763

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.394

19 October 2017

0 references

cites work

Value of CA 15:3 in the follow-up of breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Evaluation of MSA as a serum marker in breast cancer: A comparison with CEA

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Serum CA 15-3 assay in the diagnosis and follow-up of breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

A quantitative approach to determining disease response during therapy using multiple biologic markers.Application to carcinoma of the breast

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Tumour markers in breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Multivariate biochemical indicators of breast cancer: An evaluation of their potential in routine practice

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Simultaneous assays of cancer-associated antigens in various neoplastic disorders

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

A biochemical approach to the staging of human breast cancer

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Comparative evaluation of carcinoembryonic antigen and gross cystic disease fluid protein as plasma markers for human breast carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977677

Assessment of four monoclonal antibodies as serum markers in breast cancer

17 August 2018

1 reference

12 December 2020

Markers in breast cancer: does CEA add to the detection by CA 15.3?

1 reference

12 December 2020

Comparison of circulating MAM-6 and CEA levels and correlation with the estrogen receptor in patients with breast cancer

1 reference

12 December 2020

Factors predicting the response of patients with advanced breast cancer to endocrine (Megace) therapy

1 reference

12 December 2020

The definition of the ‘no change’ category in patients treated with endocrine therapy and chemotherapy for advanced carcinoma of the breast

1 reference

12 December 2020

Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers

1 reference

12 December 2020

Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen

1 reference

12 December 2020

Screening for metastases in breast cancer: an assessment of biochemical and physical methods

1 reference

12 December 2020

Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen

1 reference

12 December 2020

Steroid receptors in early breast cancer: Value in prognosis

1 reference

12 December 2020

Significance of serum concentrations of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer

1 reference

12 December 2020

Biologic markers in breast carcinoma. IV. Serum fucose-protein ratio. Comparisons with carcinoembryonic antigen and human chorionic gonadotrophin

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.394

1 reference

19 October 2017

1 reference

19 October 2017

1 reference